CN108484757A - A kind of pseudorabies virus antiserum and preparation method thereof - Google Patents

A kind of pseudorabies virus antiserum and preparation method thereof Download PDF

Info

Publication number
CN108484757A
CN108484757A CN201810377114.6A CN201810377114A CN108484757A CN 108484757 A CN108484757 A CN 108484757A CN 201810377114 A CN201810377114 A CN 201810377114A CN 108484757 A CN108484757 A CN 108484757A
Authority
CN
China
Prior art keywords
pseudorabies
virus
vaccine
serum
pseudoabies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810377114.6A
Other languages
Chinese (zh)
Inventor
李翠
赵启祖
王在时
万建青
徐璐
徐嫄
朱元源
邹兴启
张乾义
王琴
郎洪武
夏应菊
蒋卉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Institute of Veterinary Drug Control
Original Assignee
China Institute of Veterinary Drug Control
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Institute of Veterinary Drug Control filed Critical China Institute of Veterinary Drug Control
Priority to CN201810377114.6A priority Critical patent/CN108484757A/en
Publication of CN108484757A publication Critical patent/CN108484757A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention relates to a kind of pseudoabies disease virus antiseras and preparation method thereof.The present invention is directed to provide the pseudorabies virus positive serum met the requirements for the monitoring of pseudoabies diagnostic techniques, diagnostic reagent and porcine pseudorabies vaccine quality.Pseudorabies virus positive serum specificity according to the present invention is high, and neutralization titer is up to 1:2000 times or more, the exogenous virus that can meet pseudorabies living vaccines is examined and diagnostic test;In addition, animal is immunized in the invention and uses the healthy goat without containing pig source common causative, is easy to control on the degree of purity of experimental animal, immunogene is pseudoabies inactivated vaccine and live vaccine, it is easy to get and avoids being immunized using the strong poison of pseudorabies virus, reduce bio-safety risk;Merely through five immune antiserums that can obtain high-titer, method is simple, is suitble to extensive prepare.

Description

A kind of pseudorabies virus antiserum and preparation method thereof
Technical field
The present invention relates to a kind of pseudorabies virus antiserums and preparation method thereof, belong to veterinary biologics technology neck Domain.
Background technology
Pseudoabies (Aujeszkys disease) is by I type of Alphaherpesvirinae herpesvirus suis in herpetoviridae A kind of caused acute infectious disease is current one of most serious infectious disease in the world, and is widely current in China, is had resulted in tight Weight economic loss.Pseudo- mad dog diagnostic techniques, diagnostic reagent and vaccine etc. are the key that the anti-systems of the disease.The diagnostic techniques of the disease and Vaccine quality monitoring is required for pseudorabies virus positive serum, but current have not been reported can meet the pseudorabies virus used The preparation method of hyper-immune serum.The present invention is for the first time immunized goat with pseudorabies living vaccines and inactivated vaccine, is had There is the specific positive serum of high neutralization titer, and make the pure property of serum more easy to control and reliable, meets pseudoabies The exogenous virus of live vaccine is examined and diagnostic test.
Invention content
The purpose of the present invention:A kind of tool for needed for the inspection of pseudorabies living vaccines exogenous virus and diagnostic test is provided There is the specific pseudorabies virus antiserum of high neutralization titer.
Technical scheme of the present invention
1. a kind of pseudorabies virus antiserum, it is characterised in that the pseudorabies virus antiserum is normal using no swine disease See that the goat of pathogen is prepared, and the antiserum neutralization titer is up to 1:2000 times or more, it can be used for pseudoabies work epidemic disease The exogenous virus of seedling is examined and diagnostic test.
2. a kind of sero-fast preparation method of pseudorabies virus, it is characterised in that the sero-fast preparation method is:
(1) experimental animal:For the goat without swine disease common causative;
(2) immunogene:Using the pseudoabies inactivated vaccine and live vaccine of commercialization;
(3) preparation of hyper-immune serum:Examine qualified experiment with goat with pseudoabies inactivated vaccine and live vaccine altogether into Row is repeatedly immune, the pseudo- Rabies virus antibody potency of detection before being immunized every time, and last time is immunized latter all serum neutralize antibody titers and reaches It is taken a blood sample to peak value using arteria carotis to immune sheep lethal, detaches serum;
(4) inspection of hyper-immune serum:
1) physical behavior, steriling test, mycoplasma are examined:Meet the requirements;
2) titration:The neutralization titer that hyper-immune serum is measured with neutralization test and ELISA method, up to 1:2000 or more;
3) specific assay:Detect aftosa, swine fever, porcine reproductive and respiratory syndrome, porcine parvovirus, pig circular ring virus 2 Viral disease, pseudoabies and bovine viral diarrhoea/mucosal disease antibody, are feminine gender;
4) exogenous virus is examined:No exogenous virus pollution.
The specific implementation mode of the present invention
1. the preparation of pseudorabies virus specific antisera
(1) experimental animal:Or so 6 monthly ages, not not immune aftosa goat, BVDV, pseudoabies, cloth Lu Shi Bacterium disease, blue tongue disease, peste des petits ruminants and sheep pox antibody are feminine gender.
(2) immunogene:Pseudoabies inactivated vaccine and pseudorabies living vaccines
(3) immune programme:Multi-time no is carried out with pseudoabies inactivated vaccine and pseudorabies living vaccines with goat to testing Epidemic disease.
(4) prepared by serum:The situation of change of antibody level after latter week blood sampling monitoring is immunized is immunized every time.Last time is exempted from The latter all antibody levels of epidemic disease reach highest, and arteria carotis blood sampling is lethal, detaches serum.- 20 DEG C of freezen protectives, it is spare.
2. the sero-fast inspection of pseudorabies virus
1. steriling test:According to Republic of China Veterinary Pharmacopoeia (the Chinese veterinary pharmacopoeia committee, People's Republic of China (PRC) beast Pharmacopeia, two 〇 First Five-Year Plans year version three, Chinese agriculture publishing house, 2016, hereinafter referred to as《Chinese veterinary pharmacopoeia》) as defined in method carry out nothing Bacterium is examined or purely examines, and asepsis growth is answered.
2. mycoplasma is examined:According to《Chinese veterinary pharmacopoeia》Defined method carries out mycoplasma inspection, should be grown without mycoplasma.
3. neutralization titer measures
According to《Chinese veterinary pharmacopoeia》Defined method carries out in neutralization test measurement serum and 200TCID50Pseudoabies disease Malicious Bartha plants of neutralization titer,
4. specific assay:Detect aftosa, swine fever, porcine reproductive and respiratory syndrome, porcine parvovirus, pig circular ring virus 2 Viral disease and bovine viral diarrhoea/mucosal disease antibody should be negative, and pseudorabies virus antibody is the positive;
5. exogenous virus is examined:It should be polluted without exogenous virus.
The positive effect of the present invention
The present invention relates to a kind of pseudoabies disease virus antiseras and preparation method thereof.The present invention is directed to be examined for pseudoabies Disconnected technology, diagnostic reagent and the monitoring of porcine pseudorabies vaccine quality provide the pseudorabies virus positive serum met the requirements. Pseudorabies virus positive serum specificity according to the present invention is high, and neutralization titer is up to 1:2000 times or more, it can meet The exogenous virus of pseudorabies living vaccines is examined and diagnostic test;In addition, animal is immunized in the invention using normal without containing pig source The healthy goat for seeing pathogen, is easy to control on the degree of purity of experimental animal, and immunogene is pseudoabies inactivated vaccine and work Vaccine is easy to get and avoids being immunized using the strong poison of pseudorabies virus, reduces bio-safety risk;Merely through five times The immune antiserum that can obtain high-titer, method is simple, is suitble to extensive prepare.Pseudorabies virus pseudoabies The live vaccine present invention improves this to solve the problems in pseudoabies diagnostic techniques, diagnostic reagent and vaccine quality monitoring The inspection work of industry, while escorting for the promotion of the industry products quality and the safety of aquaculture.Pseudorabies virus Pseudorabies virus
Embodiment
Following embodiment is to better illustrate the present invention, is not limited the invention.
Embodiment 1
--- the preparation of pseudorabies virus specific antisera
1. experimental animal:Or so 6 monthly ages, the goat for being not suffering from not immune aftosa, and BVDV, pseudo- mad dog after testing Disease, brucellosis, blue tongue disease, peste des petits ruminants and sheep pox antibody are feminine gender.
2. immunogene:Pseudoabies inactivated vaccine and pseudorabies living vaccines
3. immune programme:
Qualified experiment is examined repeatedly to be immunized with pseudoabies inactivated vaccine and pseudorabies living vaccines with goat.
4. prepared by serum
The situation of change of antibody level after latter week blood sampling monitoring is immunized is immunized every time.Latter Zhou Kangti is immunized in last time Level reaches highest, and arteria carotis blood sampling is lethal, detaches serum.- 20 DEG C of freezen protectives, it is spare.
Embodiment 2
--- the sero-fast inspection of pseudorabies virus
1. steriling test:According to Republic of China Veterinary Pharmacopoeia (the Chinese veterinary pharmacopoeia committee, People's Republic of China (PRC) beast Pharmacopeia, two 〇 First Five-Year Plans year version (three), Chinese agriculture publishing house, 2016, hereinafter referred to as《Chinese veterinary pharmacopoeia》) as defined in method carry out Steriling test is purely examined, asepsis growth.
2. mycoplasma is examined:According to《Chinese veterinary pharmacopoeia》Defined method carries out mycoplasma inspection, no mycoplasma growth.
3. neutralization titer measures
According to《Chinese veterinary pharmacopoeia》Defined method carries out in neutralization test measurement serum and 200TCID50Pseudoabies disease Malicious Bartha plants of neutralization titer, test result are shown in Table 1.
Pseudorabies virus Specific serum antibodies level monitoring result prepared by 1 present invention of table
Number of animals 1 2 3 4
Before head exempts from 0 0 0 0
Before second immune 1:4 1:4 1:16 1:8
Before third time is immune 1:32 1:16 1:64 1:64
Before 4th time immune 1:128 1:64 1:256 1:256
Before 5th time immune 1:1024 1:256 1:1024 1:1024
Before 6th time immune 1:5623 1:2506 1:8192 1:2818
Test result shows that pseudorabies virus antibody neutralization titer after the 5th is immune reaches peak value, suitable at this moment Between largely taken a blood sample.
4. specific assay:Detect aftosa, swine fever, porcine reproductive and respiratory syndrome, porcine parvovirus, pig circular ring virus 2 Viral disease and bovine viral diarrhoea/mucosal disease antibody, are feminine gender, and pseudoabies antibody is the positive;
5. exogenous virus is examined:No exogenous virus pollution.
Embodiment 3
--- pseudorabies virus specific serum is examined for pseudorabies living vaccines diagnostic test and exogenous virus
1. pseudorabies living vaccines (Bartha-K61 plants), viral level 106.0TCID50/ head part.
2. test method:
According to《Chinese veterinary pharmacopoeia》With《Pseudorabies living vaccines》Quality standard (CVP3/2015/HYM/029) is differentiated It examines and exogenous virus is examined.
3. diagnostic test:
To determine that the serum can be used for the diagnostic tests of pseudorabies living vaccines, vaccine is diluted to 2.0 × 102.0TCID50The vaccine diluent of/0.1mL, then carried out with solution after 4 times of dilutions of PBS (1/15mol/L, pH7.2) with the serum Mixed in equal amounts, after neutralizing 90min at 37 DEG C, inoculating cell sets 37 DEG C of cultures.The control group for not neutralizing vaccine is set simultaneously, sets same item It is cultivated under part.Observation 7 days judges result.Characteristic cytopathy should occur in cellular control unit, and neutralization group cell is answered acellular Lesion.
Test result shows that the serum can be used for the diagnostic test of pseudorabies living vaccines twice.
4. exogenous virus is examined
To determine that the serum can be used for the exogenous virus inspection of pseudorabies living vaccines, according to current edition《Chinese veterinary pharmacopoeia》 Three progress exogenous virus inspections, by 1ml serum and 1 part pseudorabies living vaccines (Bartha-K61 plants) (viral level 106.0TCID50/ head part) mixing after, is neutralized 1 hour at 37 DEG C, be respectively adopted Vero cells, MDBK cells and PK-15 cells biography 3 cultures of generation.Per generation observation 7 days, judges result.Neutralization group cell answers acellular lesion.
Test result shows the pseudorabies living vaccines (Bartha-K61 plants) of 1ml serum energy 1 part of complete neutralization twice (viral level 106.0TCID50/ head part).
5. conclusion
Pseudorabies virus specific antisera can be used for pseudorabies living vaccines (Bartha-K61 plants) diagnostic test and Exogenous virus is examined.

Claims (2)

1. a kind of pseudorabies virus antiserum, it is characterised in that the pseudorabies virus hyper-immune serum be using goat prepare and At;And the neutralization titer of the hyper-immune serum is up to 1:2000 times or more, it can be used for the exogenous virus of pseudorabies virus live vaccine Inspection and diagnostic test.
2. a kind of sero-fast preparation method of Pseudorabies virus, it is characterised in that:
(1) experimental animal:For the healthy goat without swine disease common causative;
(2) immunogene:Swine pseudorabies vaccine and pseudorabies disease live-vaccine;
(3) preparation of hyper-immune serum:Qualified experiment is examined to be lived with swine pseudorabies vaccine and porcine pseudorabies with goat Vaccine is immunized, and immune preceding using the pseudo- Rabies virus antibody potency of ELISA method detection every time, latter all serum is immunized in last time Neutralize antibody titers reach peak value, lethal, the sterile separation serum of arteria carotis blood sampling;
(4) inspection of hyper-immune serum:
1) it is qualified to be examined through physical behavior, steriling test, mycoplasma;
2) titration:Sero-fast neutralization titer is measured with neutralization test;
3) specific assay:Detect aftosa, swine fever, porcine reproductive and respiratory syndrome, porcine parvovirus, Porcine circovirus desease It is feminine gender with the antibody such as bovine viral diarrhoea/mucosal disease, pseudoabies antibody is the positive;
4) exogenous virus is examined:No exogenous virus pollution.
CN201810377114.6A 2018-04-25 2018-04-25 A kind of pseudorabies virus antiserum and preparation method thereof Pending CN108484757A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810377114.6A CN108484757A (en) 2018-04-25 2018-04-25 A kind of pseudorabies virus antiserum and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810377114.6A CN108484757A (en) 2018-04-25 2018-04-25 A kind of pseudorabies virus antiserum and preparation method thereof

Publications (1)

Publication Number Publication Date
CN108484757A true CN108484757A (en) 2018-09-04

Family

ID=63314083

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810377114.6A Pending CN108484757A (en) 2018-04-25 2018-04-25 A kind of pseudorabies virus antiserum and preparation method thereof

Country Status (1)

Country Link
CN (1) CN108484757A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122447A (en) * 1989-01-23 1992-06-16 Iowa State University Research Foundation, Inc. Method of detecting pseudorabies virus specific serum antibody by use of a universal diagnostic antigen
CN101862452A (en) * 2010-07-22 2010-10-20 山西芮城亚宝兽药有限公司 Method for preparing swine multi-valent antiserum compound preparation
CN102353783A (en) * 2011-06-29 2012-02-15 武汉科前动物生物制品有限责任公司 Kit for detecting pig pseudorabies virus antibodies and block enzyme-linked immuno sorbent assay (ELISA) method
CN105732807A (en) * 2016-02-24 2016-07-06 福州大北农生物技术有限公司 Porcine pseudorabies virus positive serum preparation method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122447A (en) * 1989-01-23 1992-06-16 Iowa State University Research Foundation, Inc. Method of detecting pseudorabies virus specific serum antibody by use of a universal diagnostic antigen
CN101862452A (en) * 2010-07-22 2010-10-20 山西芮城亚宝兽药有限公司 Method for preparing swine multi-valent antiserum compound preparation
CN102353783A (en) * 2011-06-29 2012-02-15 武汉科前动物生物制品有限责任公司 Kit for detecting pig pseudorabies virus antibodies and block enzyme-linked immuno sorbent assay (ELISA) method
CN105732807A (en) * 2016-02-24 2016-07-06 福州大北农生物技术有限公司 Porcine pseudorabies virus positive serum preparation method

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
H J NAUWYNCK等: "Effect of specific antibodies on the cell-associated spread of pseudorabies virus in monolayers of different cell types", 《ARCH VIROL》 *
孟日增等: "猪伪狂犬病病毒多克隆抗体的制备及免疫学活性研究", 《中国畜牧兽医》 *
王玉玲: "猪伪狂犬病病毒高免血清的制备及应用", 《福建畜牧兽医》 *
秦刚: "不同免疫程序对制备狂犬病抗血清的免疫效果比较", 《山东畜牧兽医》 *

Similar Documents

Publication Publication Date Title
Singh et al. Buffalopox: an emerging and re-emerging zoonosis
Afshar et al. Viruses associated with bovine semen.
Ackermann et al. Round table on infectious bovine rhinotracheitis/infectious pustular vulvovaginitis virus infection diagnosis and control
König et al. Innocuousness and safety of classical swine fever marker vaccine candidate CP7_E2alf in non-target and target species
Engels et al. Interactions of bovine and caprine herpesviruses with the natural and the foreign hosts
Sakoda et al. Development and evaluation of indirect enzyme-linked immunosorbent assay for a screening test to detect antibodies against classical swine fever virus
Nixon et al. Serological comparisons of antigenically related herpesviruses in cattle, red deer and goats
CN105548536B (en) A kind of preparation method of Latex agglutination test Positive Sera
CN110105447A (en) A kind of preparation method of porcine pseudorabies virus hyper-immune serum
Böttcher et al. Epidemiologically non-feasible singleton reactors at the final stage of BoHV1 eradication: serological evidence of BoHV2 cross-reactivity
Neher et al. Detection and isolation of Duck Plague virus from field outbreaks in Assam, India
CN105445457B (en) Detect the monoclonal antibody and kit of carrying Cap gene of porcine circovirus type 2
CN108484757A (en) A kind of pseudorabies virus antiserum and preparation method thereof
CN103805571A (en) Preparation method of ascitic-type avian influenza monoclonal antibody and hybridoma cell strain as well as avian influenza immunodetection kit
CN104288760A (en) Vaccine composition, and preparation method and application thereof
Said et al. Trials for isolation of contagious pustular dermatitis virus (CPDV) from sheep in Ismailia governorate
CN102727881A (en) Highly pathogenic porcine reproductive and respiratory syndrome JXAl-R strain- porcine parvovirus disease bigeminal live vaccine and preparation method and application thereof
CN113049816B (en) Method for measuring titer of newcastle disease virus
Yilmaz et al. Investigation of Bovine Herpes Virus type 1 infection in sheep in the Kars Province of Turkey
Yazici et al. The first serological report for genotype C bovine parainfluenza 3 virus in ruminant species of mid-northern Turkey: traces from the past.
CN108300703A (en) Deer source bovine viral diarrhoea inactivated vaccine and preparation method thereof
CN101380470B (en) Pig parvovirus live vaccine
Masiuk et al. Endemic course of epidemic diarrhea of pigs in the stabilized focus of infection
Lobova et al. Prevalence of etiological agents of selected respiratory infections in chicken and turkey farms in the Czech Republic.
Seyfi Abad Shapouri et al. Isolation of Bovine Herpesvirus-1 (BoHV-1) From Latently Infected/Carrier Cattle in Ahvaz

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180904